Evidence map›Paper›PMID 29500691›Full record

ArticleVirologica Sinica2018

Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China.

Ning Wang, Shi-Yue Li, Xing-Lou Yang, Hui-Min Huang, Yu-Ji Zhang, Hua Guo, Chu-Ming Luo, Maureen Miller, Guangjian Zhu, Aleksei A Chmura and 6 more

Abstract readLetter
In one paragraph

Article in Virologica Sinica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Targeting G9a-miScience · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ning WangCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Shi-Yue LiSchool of Health Sciences, Wuhan University, Wuhan, 430071, China.
Xing-Lou YangCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Hui-Min HuangSchool of Health Sciences, Wuhan University, Wuhan, 430071, China.
Yu-Ji ZhangCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Hua GuoCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Chu-Ming LuoCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Maureen MillerEcoHealth Alliance, New York, NY, 10001, USA.
Guangjian ZhuEcoHealth Alliance, New York, NY, 10001, USA.
Aleksei A ChmuraEcoHealth Alliance, New York, NY, 10001, USA.
Emily HaganEcoHealth Alliance, New York, NY, 10001, USA.
Ji-Hua ZhouYunnan Provincial Key Laboratory for Zoonosis Control and Prevention, Yunnan Institute of Endemic Diseases Control and Prevention, Dali, 671000, China.
Yun-Zhi ZhangYunnan Provincial Key Laboratory for Zoonosis Control and Prevention, Yunnan Institute of Endemic Diseases Control and Prevention, Dali, 671000, China.
Lin-Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, 169857, Singapore.
Peter DaszakEcoHealth Alliance, New York, NY, 10001, USA.
Zheng-Li ShiCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China. zlshi@wh.iov.cn.ORCID 0000-0001-8089-163X

Funding

Understanding the Risk of Bat Coronavirus EmergenceR01AI110964 · NIAID · ECOHEALTH ALLIANCE, INC. · PI DASZAK, PETER · 2014 to 2023
$4.3M
NIAID NIH HHS R01 AI110964
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Serologic TestsAdolescentAdultAgedAged, 80 and overAnimalsAntibodies, ViralChildChinaChiropteraEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedSevere Acute Respiratory SyndromeAntibodies, Viral

Identifiers

PMID29500691
PMCPMC6178078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.